Live market news
Stocks
ARX

Accelerant Holdings

ARXStockUSA

See in Charts

Latest news on ARXranked by Oyticker for market impact

72Impact
PositiveMajor information5 Oct 2026 · 05:00 UTC · Global · Medium term
ARX Symphony RCT Shows Improved Diabetic Foot Ulcer Healing
Aroa Biosurgery announced positive results from a prospective, multicenter randomized controlled trial of its Symphony product for diabetic foot ulcer treatment. The trial demonstrated statistically significant improvement in healing outcomes.
ARXMedical DevicesBiotechnologyHealthcare

SEC filings

What ARX filed

All its filings

23 Sept 2026
Other event (opens the document on sec.gov)8-K
13 Aug 2026
Material agreement (opens the document on sec.gov)8-K
13 Aug 2026
Quarterly report (opens the document on sec.gov)10-Q
13 Aug 2026
Results announced (opens the document on sec.gov)8-K
Other event
29 May 2026
Investor communication (opens the document on sec.gov)8-K
13 May 2026
Quarterly report (opens the document on sec.gov)10-Q
13 May 2026
Results announced (opens the document on sec.gov)8-K
Investor communication
12 May 2026
Shareholder vote results (opens the document on sec.gov)8-K

From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.

Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.

Latest news on ARXranked by Oyticker for market impact

ARX Symphony RCT Shows Improved Diabetic Foot Ulcer Healing

What ARX filed